Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Predictors of Acute Liver Failure in Patients With Acute Hepatitis A: An Analysis of the 2016-2018 San Diego County Hepatitis A Outbreak.

Jiang AA, Greenwald HS, Sheikh L, Wooten DA, Malhotra A, Schooley RT, Sweeney DA.

Open Forum Infect Dis. 2019 Nov 5;6(11):ofz467. doi: 10.1093/ofid/ofz467. eCollection 2019 Nov.

2.

What's Old is New Again - Bacteriophage Therapy in the 21st century.

Aslam S, Schooley RT.

Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01987-19. doi: 10.1128/AAC.01987-19. [Epub ahead of print]

PMID:
31685458
3.

Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

Comia I, Madureira AC, Schooley RT, Vieira ML, Noormahomed EV.

EC Microbiol. 2018 Dec;14(12):813-821. Epub 2018 Nov 27.

4.

Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant.

Meewan I, Zhang X, Roy S, Ballatore C, O'Donoghue AJ, Schooley RT, Abagyan R.

ACS Omega. 2019 Oct 2;4(16):16999-17008. doi: 10.1021/acsomega.9b02491. eCollection 2019 Oct 15.

5.

The Virome of Cerebrospinal Fluid: Viruses Where We Once Thought There Were None.

Ghose C, Ly M, Schwanemann LK, Shin JH, Atab K, Barr JJ, Little M, Schooley RT, Chopyk J, Pride DT.

Front Microbiol. 2019 Sep 6;10:2061. doi: 10.3389/fmicb.2019.02061. eCollection 2019.

6.

Octadecyloxyethyl benzyl tenofovir: A novel tenofovir diester provides sustained intracellular levels of tenofovir diphosphate.

Beadle JR, Aldern KA, Zhang XQ, Valiaeva N, Hostetler KY, Schooley RT.

Antiviral Res. 2019 Nov;171:104614. doi: 10.1016/j.antiviral.2019.104614. Epub 2019 Sep 21.

PMID:
31550449
7.

Linked dual-class HIV resistance mutations are associated with treatment failure.

Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW.

JCI Insight. 2019 Oct 3;4(19). pii: 130118. doi: 10.1172/jci.insight.130118.

8.

Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.

Zhu S, Meng Q, Schooley RT, An J, Xu Y, Huang Z.

Molecules. 2019 Aug 13;24(16). pii: E2928. doi: 10.3390/molecules24162928.

9.

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.

Grinsztejn B, Hughes MD, Ritz J, Salata R, Mugyenyi P, Hogg E, Wieclaw L, Gross R, Godfrey C, Cardoso SW, Bukuru A, Makanga M, Faesen S, Mave V, Wangari Ndege B, Nerette Fontain S, Samaneka W, Secours R, van Schalkwyk M, Mngqibisa R, Mohapi L, Valencia J, Sugandhavesa P, Montalban E, Avihingsanon A, Santos BR, Kumarasamy N, Kanyama C, Schooley RT, Mellors JW, Wallis CL, Collier AC; A5288 Team.

Lancet HIV. 2019 Sep;6(9):e588-e600. doi: 10.1016/S2352-3018(19)30146-8. Epub 2019 Jul 29.

10.

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients.

Aslam S, Courtwright AM, Koval C, Lehman SM, Morales S, Furr CL, Rosas F, Brownstein MJ, Fackler JR, Sisson BM, Biswas B, Henry M, Luu T, Bivens BN, Hamilton T, Duplessis C, Logan C, Law N, Yung G, Turowski J, Anesi J, Strathdee SA, Schooley RT.

Am J Transplant. 2019 Sep;19(9):2631-2639. doi: 10.1111/ajt.15503. Epub 2019 Jul 17.

PMID:
31207123
11.

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient.

Law N, Logan C, Yung G, Furr CL, Lehman SM, Morales S, Rosas F, Gaidamaka A, Bilinsky I, Grint P, Schooley RT, Aslam S.

Infection. 2019 Aug;47(4):665-668. doi: 10.1007/s15010-019-01319-0. Epub 2019 May 17.

PMID:
31102236
12.

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.

Dedrick RM, Guerrero-Bustamante CA, Garlena RA, Russell DA, Ford K, Harris K, Gilmour KC, Soothill J, Jacobs-Sera D, Schooley RT, Hatfull GF, Spencer H.

Nat Med. 2019 May;25(5):730-733. doi: 10.1038/s41591-019-0437-z. Epub 2019 May 8.

13.

Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.

Zhu S, Zhang C, Huang LS, Zhang XQ, Xu Y, Fang X, Zhou J, Wu M, Schooley RT, Huang Z, An J.

Molecules. 2019 Apr 13;24(8). pii: E1465. doi: 10.3390/molecules24081465.

14.

High affinity CXCR4 inhibitors generated by linking low affinity peptides.

Zhang C, Huang LS, Zhu R, Meng Q, Zhu S, Xu Y, Zhang H, Fang X, Zhang X, Zhou J, Schooley RT, Yang X, Huang Z, An J.

Eur J Med Chem. 2019 Jun 15;172:174-185. doi: 10.1016/j.ejmech.2019.03.056. Epub 2019 Apr 1.

PMID:
30978562
15.

The Medical Education Partnership Initiative Effect on Increasing Health Professions Education and Research Capacity in Mozambique.

Noormahomed EV, Mocumbi AO, Ismail M, Carrilho C, Patel S, Nguenha A, Badaro R, Bickler S, Benson CA, Schooley RT.

Ann Glob Health. 2018 Apr 30;84(1):47-57. doi: 10.29024/aogh.14.

16.

Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics Combination.

Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, Khalifa L, Rimon A, Yerushalmy O, Bader R, Amit S, Coppenhagen-Glazer S, Henry M, Quinones J, Malagon F, Biswas B, Moses AE, Merril G, Schooley RT, Brownstein MJ, Weil YA, Hazan R.

Clin Infect Dis. 2019 Nov 13;69(11):2015-2018. doi: 10.1093/cid/ciz222.

PMID:
30869755
17.

Novel bacteriophage therapy for treatment of left ventricular assist device infection.

Aslam S, Pretorius V, Lehman SM, Morales S, Schooley RT.

J Heart Lung Transplant. 2019 Apr;38(4):475-476. doi: 10.1016/j.healun.2019.01.001. Epub 2019 Jan 7. No abstract available.

PMID:
30661974
18.

A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela.

Carlin AF, Wen J, Vizcarra EA, McCauley M, Chaillon A, Akrami K, Kim C, Ngono AE, Lara-Marquez ML, Smith DM, Glass CK, Schooley RT, Benner C, Shresta S.

PLoS Negl Trop Dis. 2018 Dec 31;12(12):e0007053. doi: 10.1371/journal.pntd.0007053. eCollection 2018 Dec.

19.

Erratum for Schooley et al., "Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection".

Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e02221-18. doi: 10.1128/AAC.02221-18. Print 2018 Dec. No abstract available.

20.

Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor.

Zhang C, Zhang H, Huang LS, Zhu S, Xu Y, Zhang XQ, Schooley RT, Yang X, Huang Z, An J.

Molecules. 2018 Nov 20;23(11). pii: E3036. doi: 10.3390/molecules23113036.

21.

Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.

Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S.

Cell Host Microbe. 2018 Nov 14;24(5):743-750.e5. doi: 10.1016/j.chom.2018.09.015.

22.

The Evolution of Mentorship Capacity Development in Low- and Middle-Income Countries: Case Studies from Peru, Kenya, India, and Mozambique.

Noormahomed E, Williams P, Lescano AG, Raj T, Bukusi EA, Schooley RT, Cohen CR.

Am J Trop Med Hyg. 2019 Jan;100(1_Suppl):29-35. doi: 10.4269/ajtmh.18-0560.

23.
24.

Monitoring of Delay to Pharmacy Refill in Assessing Adherence to Antiretroviral Therapy.

Cruz CCP, Mistro S, Mendes CMC, Schooley RT, da Silva Badaró RJ.

J Pharm Pract. 2018 Aug 20:897190018795339. doi: 10.1177/0897190018795339. [Epub ahead of print]

PMID:
30122111
25.

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.

Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ.

J Infect Dis. 2018 Nov 5;218(12):1954-1963. doi: 10.1093/infdis/jiy479.

26.

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection.

LaVergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D.

Open Forum Infect Dis. 2018 Mar 23;5(4):ofy064. doi: 10.1093/ofid/ofy064. eCollection 2018 Apr.

27.

Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.

Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00954-17. doi: 10.1128/AAC.00954-17. Print 2017 Oct. Erratum in: Antimicrob Agents Chemother. 2018 Nov 26;62(12):.

28.

The Medical Education Partnership Initiative (MEPI), a collaborative paradigm for institutional and human resources capacity building between high- and low- and middle-income countries: the Mozambique experience.

Virgínia Noormahomed E, Carrilho C, Ismail M, Noormahomed S, Nguenha A, Benson CA, Mocumbi AO, Schooley RT.

Glob Health Action. 2017;10(1):1272879. doi: 10.1080/16549716.2017.1272879.

29.

A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.

Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA.

Top Antivir Med. 2017 Dec/Jan;24(4):142-151.

30.

Skating to Where the Puck Is Going to Be.

Schooley RT, Fang FC.

Clin Infect Dis. 2017 Jan 1;64(1):1-2. No abstract available.

PMID:
27986765
31.

Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus.

Logan C, Todorof K, Fiorillo SP, Campbell TB, Elder JH, Borok M, Gudza I, Gwanzura L, Ndemera B, Lochhead MJ, Benson CA, Schooley RT.

PLoS One. 2016 Sep 26;11(9):e0163616. doi: 10.1371/journal.pone.0163616. eCollection 2016.

32.

Our Warming Planet: Is the HIV-1-Infected Population in the Crosshairs.

Schooley RT.

Top Antivir Med. 2016 Jul/Aug;26(2):67-70.

33.

Nasal commensal Staphylococcus epidermidis counteracts influenza virus.

Chen HW, Liu PF, Liu YT, Kuo S, Zhang XQ, Schooley RT, Rohde H, Gallo RL, Huang CM.

Sci Rep. 2016 Jun 16;6:27870. doi: 10.1038/srep27870.

34.

Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.

Gutierrez JA, Jones KA, Flores R, Singhania A, Woelk CH, Schooley RT, Wyles DL.

J Virol Antivir Res. 2014 Oct 6;3(3). doi: 10.4172/2324-8955.1000129.

35.

A prospective observational study of bacteraemia in adults admitted to an urban Mozambican hospital.

Preziosi M, Zimba TF, Lee K, Tomas M, Kinlin S, Nhatave-Paiva C, Bene R, Paunde T, Lopes H, Kalkhoff S, Prathap V, Akrami K, Noormahomed EV, Schooley RT, Aronoff-Spencer E.

S Afr Med J. 2015 Apr 8;105(5):370-4. doi: 10.7196/samj.8780.

36.

Reply to Christopher and Kortepeter.

Schooley RT.

Clin Infect Dis. 2015 Nov 1;61(9):1489-90. doi: 10.1093/cid/civ567. Epub 2015 Jul 14. No abstract available.

PMID:
26175523
37.

Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.

Carlin AF, Aristizabal P, Song Q, Wang H, Paulson MS, Stamm LM, Schooley RT, Wyles DL.

Hepatology. 2015 Oct;62(4):1047-58. doi: 10.1002/hep.27971. Epub 2015 Aug 22.

38.

Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.

Orlov M, Smeaton LM, Kumwenda J, Hosseinipour MC, Campbell TB, Schooley RT.

PLoS One. 2015 Jun 8;10(6):e0129519. doi: 10.1371/journal.pone.0129519. eCollection 2015.

39.

Near patient CD4 count in a hospitalized HIV patient population.

Givens M, Weaver A, Bickman S, Logan C, Noormahomed EV, Patel S, Schooley RT, Benson CA, Lochhead MJ.

Cytometry B Clin Cytom. 2017 Nov;92(6):451-455. doi: 10.1002/cyto.b.21248. Epub 2015 May 27.

40.

Editorial Commentary: All's (Almost) Quiet on the Western Front: Will We Be Ready for the Next War?

Schooley RT.

Clin Infect Dis. 2015 Aug 15;61(4):503-5. doi: 10.1093/cid/civ337. Epub 2015 Apr 22. No abstract available.

PMID:
25904373
41.

Determination of receptor specificities for whole influenza viruses using multivalent glycan arrays.

Huang ML, Cohen M, Fisher CJ, Schooley RT, Gagneux P, Godula K.

Chem Commun (Camb). 2015 Mar 28;51(25):5326-9. doi: 10.1039/c4cc08613a.

42.

Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.

Li JZ, Heisey A, Ahmed H, Wang H, Zheng L, Carrington M, Wrin T, Schooley RT, Lederman MM, Kuritzkes DR; ACTG A5197 Study Team.

AIDS. 2014 Nov 28;28(18):2649-57. doi: 10.1097/QAD.0000000000000478.

43.

Innovative strategies for transforming internal medicine residency training in resource-limited settings: the Mozambique experience.

Mocumbi AO, Carrilho C, Aronoff-Spencer E, Funzamo C, Patel S, Preziosi M, Lederer P, Tilghman W, Benson CA, Badaró R, Nguenha A, Schooley RT, Noormahomed EV.

Acad Med. 2014 Aug;89(8 Suppl):S78-82. doi: 10.1097/ACM.0000000000000331.

44.

Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.

Lin JC, Habersetzer F, Rodriguez-Torres M, Afdhal N, Lawitz EJ, Paulson MS, Zhu Y, Subramanian GM, McHutchison JG, Sulkowski M, Wyles DL, Schooley RT.

J Infect Dis. 2014 Dec 15;210(12):1881-5. doi: 10.1093/infdis/jiu325. Epub 2014 Jun 6.

45.

Antigen-presenting phagocytic cells ingest malaria parasites and increase HIV replication in a tumor necrosis factor α-dependent manner.

Orlov M, Vaida F, Williamson K, Deng Q, Smith DM, Duffy PE, Schooley RT.

J Infect Dis. 2014 Nov 15;210(10):1562-72. doi: 10.1093/infdis/jiu317. Epub 2014 Jun 5.

46.

Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Erlandson KM, Gudza I, Fiorillo S, Ndemera B, Schooley RT, Gwanzura L, Borok M, Campbell TB.

Int J Infect Dis. 2014 Jul;24:6-10. doi: 10.1016/j.ijid.2014.02.006. Epub 2014 Apr 21.

47.

The fragile relationship between hepatitis C virus and its human host.

Schooley RT.

Top Antivir Med. 2014 Jan;21(5):148-51. Review.

48.

Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.

Boltz VF, Bao Y, Lockman S, Halvas EK, Kearney MF, McIntyre JA, Schooley RT, Hughes MD, Coffin JM, Mellors JW; OCTANE/A5208 Team.

J Infect Dis. 2014 Mar 1;209(5):703-10. doi: 10.1093/infdis/jit635. Epub 2014 Jan 16.

49.

Strengthening research capacity through the medical education partnership initiative: the Mozambique experience.

Noormahomed EV, Mocumbi AO, Preziosi M, Damasceno A, Bickler S, Smith DM, Funzamo C, Aronoff-Spencer E, Badaró R, Mabila F, Bila D, Nguenha A, Do Rosário V, Benson CA, Schooley RT, Patel S, Ferrão LJ, Carrilho C.

Hum Resour Health. 2013 Dec 5;11:62. doi: 10.1186/1478-4491-11-62.

50.

Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.

Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P.

Virol J. 2013 Nov 22;10:321. doi: 10.1186/1743-422X-10-321.

Supplemental Content

Loading ...
Support Center